A stable and practical etoposide-containing intravenous long-/medium-chain triglycerides-based lipid emulsion formulation: pharmacokinetics, biodistribution, toxicity, and antitumor efficacy

Bibliography

• Hande K. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998;34:1514-21
   PubMed Web of Science ®Google Scholar
• Smit E, Carney D, Harford P, A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 1989;44:631-3
   PubMed Web of Science ®Google Scholar
• Hande KR, Wedlund PJ, Noone RM, Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients. Cancer Res 1984;44:379-82
   PubMed Web of Science ®Google Scholar
• O'dwyer PJ, Leyland-Jones B, Alonso MT, Etoposide (VP-16–213). N Engl J Med 1985;312:692-700
   PubMed Web of Science ®Google Scholar
• Shah JC, Chen JR, Chow D. Preformulation study of etoposide: identification of physicochemical characteristics responsible for the low and erratic oral bioavailability of etoposide. Pharm Res 1989;6:408-12
   PubMed Web of Science ®Google Scholar
• O'dwyer P, Weiss R. Hypersensitivity reactions induced by etoposide. Cancer Treat Rep 1984;68:959-61
   PubMedGoogle Scholar
• Sengupta S, Tyagi P, Velpandian T, Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res 2000;42:459-64
   PubMed Web of Science ®Google Scholar
• Sengupta S, Tyagi P, Chandra S, Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor. Pharmacology 2001;62:163-71
   PubMed Web of Science ®Google Scholar
• Ukawalal M, Chaudhari K, Rajyaguru T, Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis. J Drug Target 2012;20:55-66
   PubMed Web of Science ®Google Scholar
• Yadav KS, Jacob S, Sachdeva G, Intracellular delivery of etoposide loaded biodegradable nanoparticles: cytotoxicity and cellular uptake studies. J Nanosci Nanotechnol 2011;11:6657-67
   PubMed Web of Science ®Google Scholar
• Yadav KS, Chuttani K, Mishra AK, Effect of Size on the Biodistribution and Blood Clearance of Etoposide-Loaded PLGA Nanoparticles. PDA J Pharm Sci Technol 2011;65:131-9
   PubMedGoogle Scholar
• Yadav KS, Sawant KK. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation. Curr Drug Deliv 2010;7:51-64
   PubMedGoogle Scholar
• Snehalatha M, Venugopal K, Saha RN, Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99 m. Drug Deliv 2008;15:277-87
   PubMed Web of Science ®Google Scholar
• Yordanov G, Skrobanska R, Evangelatov A. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity. Colloids Surf B Biointerfaces 2013;101:215-22
   PubMed Web of Science ®Google Scholar
• Harivardhan Reddy L, Sharma RK, Chuttani K, Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice. J Control Release 2005;105:185-98
   PubMed Web of Science ®Google Scholar
• Prete ACL, Maria DA, Valduga CJ, Evaluation in melanoma bearing mice of an etoposide derivative associated to a cholesterol rich nanoemulsion. J Pharm Pharmacol 2006;58:801-8
   PubMed Web of Science ®Google Scholar
• Patlolla R, Vobalaboina V. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. J Pharm Sci 2005;94:437-45
   PubMed Web of Science ®Google Scholar
• Reddy PR, Venkateswarlu V. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. J Drug Target 2005;13:543-53
   PubMed Web of Science ®Google Scholar
• Tian L, He H, Tang X. Stability and degradation kinetics of etoposide loaded parenteral lipid emulsion. J Pharm Sci 2007;96:1719-28
   PubMed Web of Science ®Google Scholar
• Chen H, Shi S, Zhao M, A lyophilized etoposide submicron emulsion with a high drug loading for intravenous injection: preparation, evaluation, and pharmacokinetics in rats. Drug Dev Ind Pharm 2010;36:1444-53
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Reddy PR. Lipid microspheres as drug delivery systems. Indian J Pharm Sci 2001;63:450-8
   Google Scholar
• Carpentier YA, Dupont IE. Advances in intravenous lipid emulsions. World J Surg 2000;24:1493-7
   PubMed Web of Science ®Google Scholar
• Levy MY, Langerman L, Gottschalk-Sabag S, Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits. Pharm Res 1989;6:510-16
   PubMed Web of Science ®Google Scholar
• Von Dardel O, Mebius C, Mossberg T, Fat emulsion as a vechicle for diazepam, a study of 9492 patients. Br J Anaesth 1983;55:41-7
   PubMed Web of Science ®Google Scholar
• Lovell M, Johnson H, Hui HW, Less-painful emulsion formulations for intravenous administration of clarithromycin. Int J Pharm 1994;109:45-57
   Web of Science ®Google Scholar
• Suttmann H, Doenicke A, Kugler J, A new formulation of etomidate in lipid emulsion–bioavailability and venous provocation. Anaesthesist 1989;38:421-3
   PubMed Web of Science ®Google Scholar
• Cox EH, Knibbe CAJ, Koster VS, Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. Pharm Res 1998;15:442-8
   PubMed Web of Science ®Google Scholar
• Su M, Zhao M, Luo Y, Evaluation of the efficacy, toxicity and safety of vinorelbine incorporated in a lipid emulsion. Int J Pharm 2011;411:188-96
   PubMedGoogle Scholar
• Hippalgaonkar K, Majumdar S, Kansara V. Injectable Lipid Emulsions—Advancements, Opportunities and Challenges. AAPS Pharm Sci Tech 2010;11:1526-40
   PubMed Web of Science ®Google Scholar
• Koster V, Kuks P, Lange R, Particle size in parenteral fat emulsions, what are the true limitations? Int J Pharm 1996;134:235-8
   Web of Science ®Google Scholar
• Carpentier YA, Simoens C, Siderova V, Recent developments in lipid emulsions: relevance to intensive care. Nutrition 1997;13:73-8
   PubMed Web of Science ®Google Scholar
• Gao L, Zhang D, Chen M, Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int J Pharm 2008;355:321-7
   PubMed Web of Science ®Google Scholar
• Grislain L, Couvreur P, Lenaerts V, Pharmacokinetics and distribution of a biodegradable drug-carrier. Int J Pharm 1983;15:335-45
   Web of Science ®Google Scholar
• Júnior DC, Mota LG, Nunan EA, Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Sci 2007;80:659-64
   PubMed Web of Science ®Google Scholar
• Shi S, Chen H, Lin X, Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion. Int J Pharm 2010;383:264-70
   PubMed Web of Science ®Google Scholar
• Zhao M, Su M, Lin X, Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity. Pharm Res 2010;27:1687-702
   PubMed Web of Science ®Google Scholar